Mark A Bauer, Parveen Bazard, Alejandro A Acosta, Nidhi Bangalore, Lina Elessaway, Mark Thivierge, Moksheta Chellani, Xiaoxia Zhu, Bo Ding, Joseph P Walton, Robert D Frisina
The naturally occurring amino acid, l-ergothioneine (EGT), has immense potential as a therapeutic, having shown promise in the treatment of other disease models, including neurological disorders. EGT is naturally uptaken into cells via its specific receptor, OCTN1, to be utilized by cells as an antioxidant and anti-inflammatory. In our current study, EGT was administered over a period of 6 months to 25-26-month-old CBA/CaJ mice as a possible treatment for age-related hearing loss (ARHL), since presbycusis has been linked to higher levels of cochlear oxidative stress, apoptosis, and chronic inflammation...
April 2, 2024: Hearing Research